GLP-1

Class of therapeutic medications and emerging pharmaceutical market

Latest news

health58d ago1 min read

Conexeu Sciences CEO Miles Harrison Speaks on GLP-1 Market Opportunities

Conexeu Sciences CEO Miles Harrison joined a fireside chat to discuss strategic developments and commercial potential within the rapidly expanding GLP-1 healthcare market.